Bioscience Chapter Database :: 3635 Chapters Now Online

Chapter category: Viruses

Biomedical Implications

This chapter appears in the following book:

HIV and Membrane Receptors

Edited by: Dimiter Dimitrov, Christopher Broder and Garry Lynch
ISBN: 1-57059-464-3
» Get more information about this book at landesbioscience.com «

Chapter authors:
Dimitrov, Dimiter S., Christopher C. Broder

In spite of the high efficiency of the protease inhibitors, especially in combination with reverse transcriptase inhibitors, drug resistance and toxicity are of major concern and new drugs are needed to supplement the existing ones or be used as novel therapies. The identification of the HIV-1 coreceptor molecules offers a new target for development of such therapeutics. In addition, it may also suggest new opportunities for vaccine development. Unlike the recent successes in drug development, the development of vaccines is still far behind expectations and without clear indications for progress in the near future. This chapter explores the opportunities provided by the new discoveries and attempts to present a realistic picture of their potential. We begin with a description of experimental data for inhibition of viral entry by antiviral agents and the lessons which were learned and could be applied to the new story of the HIV-1 coreceptors. Then we describe recent data on inhibitory activity of agents targeting the coreceptor molecules, including their natural ligands, and discuss the potential for developing drugs. The next section is devoted to the potential of receptor molecules for development of vaccines; it is mostly speculative, and describes several possibilities including complexes of coreceptors with receptor-gp120-gp41 molecules which may expose important conserved and highly immunogenic epitopes and stimulation of chemokine production. The final section is entirely speculative (i.e., there are no published experimental data demonstrating feasibility) and suggests possible implications of the coreceptors for developing very specific gene and drug delivery systems which can be used not only for treatment of AIDS but also against cancer and other diseases.

» Access chapter for $19



Additional chapters from this book:

Receptors and Virus Infections

Dimitrov, Dimiter S. , Christopher C. Broder

Many (but not all) viruses have evolved to utilize a variety of cell surface molecules for gaining access into the cellular interior. A striking feature of virus adaptation to hosts under selective ...

Biomedical Implications

Dimitrov, Dimiter S., Christopher C. Broder

In spite of the high efficiency of the protease inhibitors, especially in combination with reverse transcriptase inhibitors, drug resistance and toxicity are of major concern and new drugs are neede...

HIV-1 Tropism and Pathogenesis

Dimitrov, Dimiter S., Christopher C. Broder

Genotypic and phenotypic variation is a hallmark of infection by HIV-1. The ability of HIV-1 to infect different types of cells varies from one isolate to the next and is referred to as cell-type tr...

Receptor-Mediated HIV Entry

Dimitrov, Dimiter S., Christopher C. Broder

Entry of enveloped viruses into cells can be conveniently divided into three main stages: first, attachment to the cell surface, second, fusion of the viral with the cellular membrane, and third, un...

The HIV-1 Coreceptors: Identification, Biological Function and Structure

Dimitrov, Dimiter S. , Christopher C. Broder

During the past decade several molecules have been proposed as accessory factors or cofactors for the HIV-1 Env-CD4-mediated membrane fusion process, detailed in the previous chapter. Until recently...

The Fusion Cofactors/Coreceptors

Dimitrov, Dimiter S. , Christopher C. Broder

The principal cell types targeted by HIV-1 in vivo are helper T lymphocytes and cells of the monocyte-macrophage lineage via the CD4 receptor pathway, the primary high affinity receptor for HIV-1.1-...

HIV Receptors

Dimitrov, Dimiter S. , Christopher C. Broder

AIDS is characterized by depletion of CD4 T lymphocytes; in 1984 it was shown that CD4 is the primary receptor for HIV-1.1,2 To characterize the HIV-1 receptor and to ascertain that the CD4 cell tro...

The HIV Envelope Glycoprotein

Dimitrov, Dimiter S. , Christopher C. Broder

The primary viral determinant which interacts with cellular receptors is the envelope glycoprotein (Env). Enveloped viruses encode one or more types of these integral membrane proteins. HIV is no ex...

HIV

Dimitrov, Dimiter S. , Christopher C. Broder

The acquired immunodeficiency syndrome (AIDS) was first recognized as a separate clinical entity (albeit initially under a different name) in 1981.1 It was characterized by immunologic abnormalities...

Virus Evolution and Structure

Dimiter S. Dimitrov, Christopher C. Broder

Viruses are intracellular parasites whose nucleic acids are encapsulated in proteins encoded by their genomes and their evolutionary history is largely independent of that of their hosts.1 More than...


SIGN IN

Email:


Password:


lost password?




[ Home | Authors | Editors | Custom Books | Chapter Reprints | Subscribe | Contact | Biotoons ]